...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Roth research report
9
Oct 31, 2018 04:21PM
5
Oct 31, 2018 09:26PM
8
Oct 31, 2018 10:20PM
3
Nov 01, 2018 03:23AM
4
Nov 01, 2018 09:14AM

Nov 01, 2018 09:20AM
3
Nov 01, 2018 09:47AM

Interesting.

I bought ACST immediately after the Amarin data was reported. The value proposition seemed impressive.

Can you expand on why you think ACST will have better data than Amarin?

I’m eager to see the hard 3 point MACE data for Vascepa.

 

bfw

2
Nov 01, 2018 04:17PM
4
bfw
Nov 01, 2018 04:36PM
Share
New Message
Please login to post a reply